1. Home
  2. JAGX vs BYAH Comparison

JAGX vs BYAH Comparison

Compare JAGX & BYAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$0.50

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

Logo Park Ha Biological Technology Co. Ltd. Ordinary Shares

BYAH

Park Ha Biological Technology Co. Ltd. Ordinary Shares

N/A

Current Price

$1.15

Market Cap

4.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
JAGX
BYAH
Founded
2013
2016
Country
United States
China
Employees
49
41
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
4.8M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
JAGX
BYAH
Price
$0.50
$1.15
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
454.2K
599.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,689,000.00
N/A
Revenue This Year
$22.41
N/A
Revenue Next Year
$30.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
19.75
N/A
52 Week Low
$0.20
$0.05
52 Week High
$15.48
$2.77

Technical Indicators

Market Signals
Indicator
JAGX
BYAH
Relative Strength Index (RSI) 39.23 53.10
Support Level N/A $0.14
Resistance Level $0.69 $2.77
Average True Range (ATR) 0.10 0.15
MACD -0.01 -0.09
Stochastic Oscillator 6.36 7.65

Price Performance

Historical Comparison
JAGX
BYAH

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About BYAH Park Ha Biological Technology Co. Ltd. Ordinary Shares

Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.

Share on Social Networks: